Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Piracetam and dyslexia: effects on reading tests.

C R Wilsher, D Bennett, C H Chase

    Journal of Clinical Psychopharmacology
    |August 1, 1987
    PubMed
    Summary

    Piracetam significantly improved reading skills and comprehension in dyslexic children over 36 weeks. This study found piracetam (a nootropic drug) to be well-tolerated and effective for dyslexia treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A new chemotherapeutic investigation: Piracetam effects on dyslexia.

    Annals of dyslexia·2013
    Same author

    The nootropic concept and dyslexia.

    Annals of dyslexia·2013
    Same author

    The effect of dextroamphetamine on habituation of peripheral vascular response in children.

    Journal of abnormal child psychology·2013
    Same author

    A brief review of studies of piracetam in dyslexia.

    Journal of psychopharmacology (Oxford, England)·2011
    Same author

    A new eschar technique for local treatment of burns.

    Surgery, gynecology & obstetrics·2010
    Same author

    Methodology of antidepressant drug trials for treating depression in adolescents.

    Journal of child and adolescent psychopharmacology·2009

    Area of Science:

    • Neuroscience
    • Developmental Psychology
    • Pharmacology

    Background:

    • Previous studies indicated piracetam may enhance cognitive functions in individuals with dyslexia.
    • Dyslexia is a neurodevelopmental disorder affecting reading acquisition.

    Purpose of the Study:

    • To evaluate the efficacy and safety of piracetam in improving reading skills in dyslexic children.
    • To assess the long-term effects of piracetam treatment on reading ability and comprehension.

    Main Methods:

    • A 36-week, multicenter, double-blind, placebo-controlled trial involving 225 dyslexic children (ages 7-12).
    • Exclusion criteria ensured a homogenous sample, excluding children with other neurological, psychiatric, or sensory impairments.
    • Standardized reading tests (Gray Oral Reading Test, Gilmore Oral Reading Test) were used for assessment.

    Related Experiment Videos

    Main Results:

    • Piracetam-treated children demonstrated statistically significant improvements in reading ability and comprehension compared to the placebo group.
    • Treatment effects were observable by 12 weeks and maintained throughout the 36-week study period.
    • Piracetam was well-tolerated, with no significant adverse clinical or laboratory effects reported.

    Conclusions:

    • Piracetam is a safe and effective therapeutic agent for enhancing reading skills and comprehension in dyslexic children.
    • The positive effects of piracetam on reading performance are sustained over a 36-week treatment period.